​

Eikon Therapeutics Ownership | Who Owns Eikon Therapeutics?


OverviewFinancialsChart

Eikon Therapeutics Ownership Summary


Eikon Therapeutics is owned by 49.29% institutional investors, 17.38% insiders, and 33.34% retail investors. Fmr is the largest institutional shareholder, holding 10.19% of EIKN shares. BGF World Healthscience A2 is the top mutual fund, with 2.81% of its assets in Eikon Therapeutics shares.

EIKN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEikon Therapeutics49.29%17.38%33.34%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr5.52M10.19%$44.38M
Blackrock funding, inc. /de4.87M8.99%$39.15M
Merck1.67M3.08%$13.40M
Capital world investors1.18M2.17%$9.45M
Vanguard capital management1.02M1.88%$8.16M
Geode capital management754.50K1.39%$6.07M
Regents of the university of california635.13K1.17%$5.11M
State street608.84K1.12%$4.90M
Soros capital management484.67K0.90%$3.90M
Walleye capital391.27K0.72%$3.15M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Soros capital management484.67K2.14%$3.90M
Merck1.67M1.63%$13.40M
Entrypoint capital47.94K0.11%$385.46K
Affinity asset advisors298.00K0.10%$2.40M
Regents of the university of california635.13K0.08%$5.11M
Dcf advisers33.79K0.06%$271.69K
Pavaki capital management10.00K0.03%$80.40K
Entropy technologies, lp15.50K0.00%$124.62K
Walleye capital391.27K0.00%$3.15M
Alps advisors71.25K0.00%$572.89K

Top Buyers

HolderShares% AssetsChange
Regents of the university of california635.13K0.08%635.13K
Blackrock funding, inc. /de4.87M0.00%587.85K
Fmr5.52M0.00%526.25K
Walleye capital391.27K0.00%391.27K
State street608.84K0.00%254.75K

Top Sellers

HolderShares% AssetsChange
Jane street group---265.00K
Wellington management group llp---185.00K
Sixth street partners management company---182.10K
Blackstone---168.34K
Goldman sachs group---129.31K

New Positions

HolderShares% AssetsChangeValue
Regents of the university of california635.13K0.08%635.13K$5.11M
Walleye capital391.27K0.00%391.27K$3.15M
Los angeles capital management63.83K0.00%63.83K$513.19K
Entrypoint capital47.94K0.11%47.94K$385.46K
Dcf advisers33.79K0.06%33.79K$271.69K

Sold Out

HolderChange
Quantbot technologies lp-1.10K
Strs ohio-4.30K
Landscape capital management-10.38K
Hudson bay capital management lp-13.48K
Axq capital, lp-15.41K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20267850.00%26,687,46212.40%492.56%555.77%9-
Mar 31, 202652-23,743,113-43-52---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
BGF World Healthscience A21.52M2.81%-
Fidelity Contrafund1.27M2.35%-2.08K
Fidelity Select Biotechnology1.17M2.16%18.20K
American Funds SMALLCAP World A1.14M2.11%-
T. Rowe Price Small-Cap Value848.85K1.57%-
Fidelity Growth Compy Commingled Pl S839.77K1.55%34.50K
iShares Russell 2000 ETF788.07K1.45%-
T. Rowe Price New Horizons739.38K1.36%-91.63K
Fidelity Growth Company Fund730.92K1.35%97.60K
BlackRock Health Sciences Opps Inv A722.39K1.33%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 03, 2026Column Group IV GP, LP-Buy$1.03M

EIKN Ownership FAQ


Who Owns Eikon Therapeutics?

Eikon Therapeutics shareholders are primarily institutional investors at 49.29%, followed by 17.38% insiders and 33.33% retail investors. The average institutional ownership in Eikon Therapeutics's industry, Biotech Stocks , is 385.89%, which Eikon Therapeutics falls below.

Who owns the most shares of Eikon Therapeutics?

Eikon Therapeutics’s largest shareholders are Fmr (5.52M shares, 10.19%), Blackrock funding, inc. /de (4.87M shares, 8.99%), and Merck (1.67M shares, 3.08%). Together, they hold 22.26% of Eikon Therapeutics’s total shares outstanding.

Does Blackrock own Eikon Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Eikon Therapeutics.

Who is Eikon Therapeutics’s biggest shareholder by percentage of total assets invested?

Soros capital management is Eikon Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.14% of its assets in 484.67K Eikon Therapeutics shares, valued at 3.9M$.

Who is the top mutual fund holder of Eikon Therapeutics shares?

BGF World Healthscience A2 is the top mutual fund holder of Eikon Therapeutics shares, with 2.81% of its total shares outstanding invested in 1.52M Eikon Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools